Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LINC00551 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZNF382 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LINC00824 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF333 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RANBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102725292 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACSM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM232 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC283454 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXB9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM13A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERLIN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GMDS-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLIS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RXRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF718 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on